Nissay Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-24,045
| Closed | -$4.42M | – | 770 |
|
|
2021
Q2 | $4.42M | Buy |
24,045
+1,118
| +5% | +$205K | 0.04% | 262 |
|
|
2021
Q1 | $3.51M | Sell |
22,927
-523
| -2% | -$80K | 0.03% | 295 |
|
|
2020
Q4 | $3.66M | Sell |
23,450
-162
| -0.7% | -$25.3K | 0.06% | 265 |
|
|
2020
Q3 | $2.7M | Sell |
23,612
-5,893
| -20% | -$674K | 0.05% | 299 |
|
|
2020
Q2 | $3.31M | Buy |
29,505
+1,220
| +4% | +$137K | 0.06% | 269 |
|
|
2020
Q1 | $2.54M | Buy |
28,285
+654
| +2% | +$58.7K | 0.06% | 275 |
|
|
2019
Q4 | $2.99M | Buy |
27,631
+494
| +2% | +$53.4K | 0.07% | 308 |
|
|
2019
Q3 | $2.66M | Buy |
27,137
+1,235
| +5% | +$121K | 0.07% | 321 |
|
|
2019
Q2 | $3.39M | Sell |
25,902
-927
| -3% | -$121K | 0.09% | 261 |
|
|
2019
Q1 | $3.63M | Sell |
26,829
-692
| -3% | -$93.6K | 0.1% | 248 |
|
|
2018
Q4 | $2.68M | Buy |
27,521
+619
| +2% | +$60.3K | 0.08% | 289 |
|
|
2018
Q3 | $3.74M | Buy |
26,902
+624
| +2% | +$86.8K | 0.1% | 248 |
|
|
2018
Q2 | $3.26M | Sell |
26,278
-608
| -2% | -$75.5K | 0.1% | 256 |
|
|
2018
Q1 | $3M | Buy |
26,886
+547
| +2% | +$61K | 0.09% | 264 |
|
|
2017
Q4 | $3.15M | Buy |
+26,339
| New | +$3.15M | 0.1% | 262 |
|